186 related articles for article (PubMed ID: 7507155)
1. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
Duncan JI
J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
Staruch MJ; Sigal NH; Dumont FJ
Int J Immunopharmacol; 1991; 13(6):677-85. PubMed ID: 1721613
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
Teutsch M; Higer M; Wang D; Wortis HW
Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive macrolides FK-506 and rapamycin.
Thomson AW
Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
Sigal NH; Dumont FJ
Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
Rondeau E
Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
[No Abstract] [Full Text] [Related]
7. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.
Henderson DJ; Naya I; Bundick RV; Smith GM; Schmidt JA
Immunology; 1991 Jul; 73(3):316-21. PubMed ID: 1715317
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
Fruman DA; Klee CB; Bierer BE; Burakoff SJ
Proc Natl Acad Sci U S A; 1992 May; 89(9):3686-90. PubMed ID: 1373887
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
10. The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.
Francavilla A; Starzl TE; Carr B; Azzarone A; Carrieri G; Zeng QH; Porter KA
Transplant Proc; 1991 Dec; 23(6):2817-20. PubMed ID: 1721287
[No Abstract] [Full Text] [Related]
11. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
12. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
13. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
Dumont FJ; Kastner C; Iacovone F; Fischer PA
J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
[TBL] [Abstract][Full Text] [Related]
14. Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin.
Siekierka JJ
Immunol Res; 1994; 13(2-3):110-6. PubMed ID: 7539823
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
[TBL] [Abstract][Full Text] [Related]
16. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
[No Abstract] [Full Text] [Related]
18. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
[TBL] [Abstract][Full Text] [Related]
19. FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
Rokaw MD; West ME; Palevsky PM; Johnson JP
Am J Physiol; 1996 Jul; 271(1 Pt 1):C194-202. PubMed ID: 8760046
[TBL] [Abstract][Full Text] [Related]
20. The effect of immunosuppressive agents (FK-506, rapamycin) on renal P450 systems in rat models.
Yoshimura R; Yoshimura N; Ohyama A; Ohmachi T; Yamamoto K; Kishimoto T; Wada S
J Pharm Pharmacol; 1999 Aug; 51(8):941-8. PubMed ID: 10504034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
